Recently Gadd45, a p53-regulated stress protein, has been implicated in the activation of a G2/M checkpoint after damage by UV radiation and alkylating agents. While inhibitory phosphorylation of Cdc2 and suppression of cyclin B1 levels are known to be involved in G2 delays after genotoxic stress, Gadd45 has now been found to directly inhibit the activity of Cdc2/Cyclin B1 complex, while it had no appreciable eect on Cdk2/ Cyclin E activity even at very high levels of Gadd45. In contrast, p21
Introduction
In response to DNA damage, mammalian cells can prevent cell cycle progression by control of critical cell cycle regulators. Delay in the G2 phase after genotoxic stress appears to be governed by a series of such control systems and their inactivation can often have dramatic consequences on radiosensitivity and genomic stability (Hartwell and Kastan, 1994; O'Connor, 1997; Paulovich et al., 1997) . Many of these control mechanisms target the Cdc2/Cyclin B1 complex which is probably the major cell-cycle regulator that`drives' mammalian cells into mitosis (Elledge, 1996; O'Connor, 1997) . Many G2 regulatory factors have been well-conserved over eukaryotic evolution and evidence exists that proteins, such as Chk1, 14-3-3, and ATM (S. pombe Rad3), alter Cdc2 (Cdk1) activity after genotoxic stress by inhibiting dephosphorylation of inhibitory sites on Cdc25C (yeast Cdc25) (Elledge, 1996; O'Connor, 1997; Paulovich et al., 1997) . In addition, ionizing radiation (IR) has been shown to inhibit Cdc2 activity by inhibiting the accumulation of Cyclin B1 mRNA and protein (Bernhard et al., 1995; Maity et al., 1995) , while over-expression of Cyclin B1 was found to override the IR-induced G2 checkpoint in HeLa cells (Kao et al., 1997) .
During metazoan evolution, additional G2 control factors have probably been added such as the tumor suppressor p53. In addition to its well characterized role in G1, p53 has been implicated in G2 control as exempli®ed by the ®nding that overexpression of p53 in p53-de®cient human ®broblasts caused both G1 and G2 arrest (Agarwal et al., 1995; Stewart et al., 1995) . Evidence has been presented for a role(s) for p53 in both a spindle cell checkpoint (Cross et al., 1995) and control of centrosome duplication (Fukasawa et al., 1996) . The E6 viral oncoprotein, which blocks p53 action, has been found to decrease the stringency of mitotic checkpoints (Thompson et al., 1997) . Although the role for p53 in G2/M delay(s) is controversial (Khan and Wahl, 1998; Ko and Prives, 1996; Lanni and Jacks, 1998) and robust IR checkpoint activation can occur in p53-de®cient cells including HeLa cells (Bernhard et al., 1995; Kao et al., 1997) , ample evidence exists to indicate that p53 may aect G2/M control mechanisms. For example, several laboratories have found that p53-de®cient cells are more sensitive to G2/M checkpoint abrogators than their p53 wt counterparts (Fan et al., 1995; Powell et al., 1995) . In an g-irradiated myeloid line (Guillouf et al., 1995) , forced expression of p53 was found to hasten G2 exit and subsequent apoptosis (Guillouf et al., 1995) . Recently 14-3-3s, which can block Cdc25C action, has been found to be p53 regulated, although its role in checkpoint activation in mammalian cells after stress remains to be determined (Hermeking et al., 1997) . In the case of the p53-regulated protein p21 Cip1/Waf1 , overexpression has been reported to cause an accumulation of cells in both G1 and G2, and Cyclin B-associated kinase activity was reduced (Medema et al., 1998) . Recent data indicate that normal cellular p21
Cip1/Waf1 promotes a transient pause late in G2 (Dulic et al., 1998) . Unlike the situation for the p53-mediated G1 checkpoint, regulation of the G2 checkpoint(s) after genotoxic stress is probably complex and may well involve redundant controls involving both p53-independent and p53-dependent mechanisms.
In the case of the p53-regulated protein Gadd45, its role in growth control remains to be elucidated. Like CIP1/WAF1, GADD45 is regulated by both p53 dependent and independent mechanisms with evidence for responsiveness to genotoxic stresses, particularly UV radiation and alkylating agents, in all mammalian cells examined to date . After transient transfection with expression vectors, GADD45 has been found to suppress cell growth to a similar level as CIP1/WAF1 , but its mechanism(s) of action is uncertain and association with cdk/cyclin complexes has not been reported. This acidic protein has been reported to associate with PCNA and p21
Cip1/Waf1 (Kearsey et al., 1995) , but the biologic signi®cance of these associations is uncertain. A recent lead in Gadd45 function was the observation that over-expression of this protein caused a G2/M arrest in normal human ®broblasts following microinjection of a GADD45 expression vector (Wang et al., 1997) and (Wang et al, submitted for publication) . This G2/M arrest was attenuated by overexpression of Cyclin B1 and Cdc25C. This phenomenon was observed in p53 wt cells, but did not require p21
Cip1/Waf1 since a similar Figure 1 Inhibitory eect of Gadd45 protein on cyclin B1/Cdc2 kinase activity. (a) Puri®ed Cdc2-cyclin B1 complexes (Upstate Biotechnology, Lake Placid, NY, USA) were incubated with the indicated amounts of recombinant Gadd45 or NAP1 proteins, and histone H1 kinase assays were then performed as described in Materials and methods. Labeled histone H1 was detected by autoradiography following size separation on a SDS ± PAGE gel. (b) Histone H1 kinase assays were carried out as in (a). Instead of loading samples onto the gel for electrophoretic analysis, 20 ml aliquots were spotted on phospocellulose paper and then washed three times with 0.75% phosphoric acid. After an acetone rinse, the radioactivity was measured by scintillation counting. The results are the average of three separate experiments. (c) Histone H1 kinase assays were carried out as in panels a and b with the indicated amounts of full-length Gadd45 or truncated forms containing the ®rst 124, Gadd45D125 ± 166, or ®rst 71, Gadd45D72 ± 166, amino acids; for comparative purposes p21 Cip1/Waf1 was also included response was found in HCT116 cells and also in a CIP1/Waf17/7 derivative. While suppression of cellular Gadd45 expression did not aect the IR checkpoint, Gadd45 was required for the normal G2 delay after treatment with UV radiation or methylmethane sulfonate, both of which produce base damage in DNA but not appreciable levels of strand breaks as is the case for IR. Considering the central role for Cdc2/Cyclin B in G2, the eect of Gadd45 on Cdc2 kinase activity was investigated.
Results
As a ®rst step to determine if Gadd45 aected Cdc2 activity, the eect of Gadd45 on Cdc2 activity in vitro was studied. As shown in Figure 1a and b, recombinant Gadd45 strongly inhibited the histone H1 kinase activity of puri®ed Cdc2/Cyclin B1. In contrast, NAP-1, a protein of similar size and charge as Gadd45, had no appreciable eect. NAP-1 was chosen as a control because our polyclonal antibody to Gadd45 cross-reacts with Set, a mammalian protein with homology to yeast NAP-1 (Carrier et al, submitted for publication). Since there is no appreciable homology with Gadd45, it was assumed that this chromatin-binding protein may have some secondary structure similiarities. Two recombinant Gadd45 deletion proteins were used in the Cdc2/cyclin B1 kinase assay in Figure 1c . Gadd45D72 ± 166 (contains residues 1 ± 71) failed to inhibit Cdc2/cyclin B1 kinase activity while Gadd45D125 ± 166 (contains residues 1 ± 124) was able to inhibit this kinase complex, suggesting that a required inhibitory domain of Gadd45 may be speci®cally localized within the region between 71 and 124 residues. It is interesting to note that Gadd45 inhibited Cdc2/Cyclin B1 activity at least as strongly as the universal cyclin cdk inhibitor p21
Cip1/Waf1
; e.g., 50 ng Figure 2 Inhibition of Cdc2/Cyclin B1 but not Cdk2/Cyclin E kinase activity by Gadd45. One mg of cellular proteins was immunoprecipitated with anti-cyclin B1 antibody (a), anti-cyclin E (b and c) and protein A agarose beads as described in Materials and methods. Samples were then incubated with the indicated amounts of Gadd45 or p21 Cip1/Waf1 (designated p21) during histone H1 kinase assays as described in Figure 1 of Gadd45 reduced the activity to less than 40% of control, while the activity with the same amount of p21 Cip1/Waf1 was only 66% of the control. With larger amounts of either of these two similar size proteins, there was strong inhibition by both Gadd45 and p21
Cip1/Waf1 in Figure 1c . A monoclonal antibody against cyclin B1 was next used to immunoprecipitate Cdc2/cyclin B1 complex from a lysate of human cells. This precipitate containing Cdc2/cyclin B1 complex displayed substantial histone H1 kinase activity as shown in Figure 2a . Addition of rGadd45 resulted in a progressive inhibition of the enzymatic activity of the isolated Cdc2/cyclin B1 complex; the presence of Cdc2/Cyclin B1 was con®rmed by immunoblotting (data not shown). In contrast, Gadd45 had no eect on Cdk2/ Figure 3 Physical association of Gadd45 with Cdc2. (a) Demonstration by ELISA assay of an interaction between Gadd45 protein and Cdc2/cyclin B1 complex. Immunoabsorption plates were coated with 100 ng of Cdc2/cyclin B1 complexes and then blocked with 5% nonfat milk. Forty ng of recombinant Gadd45 protein were added to the designated samples and this was followed by antiGadd45 antibody. Gadd45 binding was detected with a HRP-anti-rabbit antibody as described in Materials and methods. A representative experiment is also shown with truncated Gadd45 proteins spanning amino acids 1 ± 71 and 1 ± 124. (b) GST-Gadd45 fusion protein interacts with cellular Cdc2 protein. GST or GST-Gadd45 fusion protein were incubated with RKO cellular protein; complexes were then washed three times with lysis buer and analysed by SDS ± PAGE gel electrophoresis and immunoblotting with anti-Cdc2 and anti-Cyclin B1 monoclonal mouse antibodies. (c) In vivo association of cellular Cdc2 with Myc-tag-Gadd45 protein fusion protein. pCS2 (Myc-tag-vector) or pCS2-Gadd45 (Myc-tag-Gadd45) were transiently expressed in RKO cells. Whole cell protein extracts were prepared as in Figure 2 and immunoprecipitated with anti-Notch (Santa Cruz), anti-Cdc2 (Santa Cruz), anti-cMyc (9E10, Santa Cruz), anti-IgG, or anti-Ckd2 (Pharmingen) antibodies and analysed by SDS ± PAGE gel electrophoresis and immunoblotting with anti-c-Myc antibody. The position of the Myc-tagged Gadd45 is shown on the left and the position of the immunoglobin heavy and light chains on the right; the anti-Notch immunoglobin chains did not react with the HRP-conjugated anti-mouse Ab used to detect the c-Myc antibody; several non-speci®c bands were seen in the Cdk2 lanes but no binding to MycTag-Gadd45 was detected Cyclin E histone H1 kinase activity, while the kinase inhibitor staurosporine, which was included as a positive control, blocked nearly all the activity (Figure 2b ). On the other hand, p21
Cip1/Waf1 strongly inhibited Cdk2/Cyclin E ( Figure 2c ). Considering that up to 3600 ng of Gadd45 had no eect on Cdk2/Cyclin E which is a major G1 cyclin, our results indicate that Gadd45, unlike p21
, is not a general inhibitor for cyclin dependent kinases but rather is more speci®c for Cdc2.
Since there is no evidence that Gadd45 has phosphatase, kinase, or protease activity (data not shown), eorts were made to determine if the inhibition of Cdc2 kinase activity might involve a physical interaction between Gadd45 and Cdc2 that could be detected in vitro. Using an ELISA assay approach, Gadd45 protein was found to associate with puri®ed Cdc2/Cyclin B1 in Figure 3a . Only the sample containing both Cdc2, Gadd45, and Gadd45 antibody showed binding over background level, which was not appreciably dierent from wells coated with the blocking agent (nonfat milk) alone. Interaction was observed with the Gadd45D125 ± 166 deletion protein where binding was 77% of that seen with the fulllength protein, while appreciable binding was not seen with the shorter Gadd45D72 ± 166 truncated protein. This result also suggests that the region between amino acids 71 to 124 in Gadd45 may be required for the interaction of Gadd45 with Cdc2 protein and is consistent with the observation that the inhibitory domain of Gadd45 localized to this region ( Figure 1c ). An association between recombinant Gadd45 and Cdc2 present in cell lysates was also demonstrated. GST-Gadd45 fusion protein or GST alone, which were linked to Sepharose beads, were incubated with cellular lysates, isolated, and analysed by immunoblotting in Figure 3b . With this approach GST-Gadd45 was found to associate with cellular Cdc2, whereas no Cdc2 was detected with GST alone. Surprisingly, GST-Gadd45 did not associate with cyclin B1, which could indicate that Gadd45 only associates with free Cdc2 or perhaps displaces Cyclin B1 from Cdc2/Cyclin B1 complexes. No association with Cdk2 was detected in the same experiments using an antibody to Cdk2 instead of Cdc2.
In order to determine if Gadd45 associates with Cdc2 in vivo, RKO cells were transfected with Mycepitope-tagged expression vectors and then lysates from cells expressing Myc-tag-Gadd45 fusion protein or unfused Myc-tag were immunoprecipitated with antibodies to c-myc and Cdc2. Antibodies to Cdk2 or Notch, which is an unrelated human protein, and mouse IgG were included as negative controls. Following immunoblot analysis, the Myc-tagged Gadd45 protein was detected in both the cell lysate and after immunoprecipitation with anti-Myc antibody; this indicates that there was appreciable expression of this fusion protein. After immunoprecipitation with Cdc2 antibody, Myc-tagged Gadd45 was also detected, while none was detected with the control antibodies as shown in Figure 3c . Similar results were also observed with MCF-7 cells (data not shown). These results were also con®rmed with a GST-Gadd45 expression (vector) in place of the Myc-tag vector (data not shown). The results in Figure 3 indicate that Gadd45 is able to associate with Cdc2 both in vitro and in vivo.
Since Gadd45 inhibited Cdc2/Cyclin B1 activity but only associated with Cdc2, the possibility was considered that Gadd45 acts by dissociating this complex. To test this, anti-Cyclin B1 antibody was used to precipitate cellular Cdc2/cyclin B1 complexes and then a`wash o assay' was carried out in the presence of Gadd45. After washing with lysis buer followed by kinase buer, the immune complexes were incubated with the indicated amounts of either Gadd45 Figure 4 Gadd45 dissociation of Cdc2/cyclin B1 in vitro. RKO cellular protein was prepared as in Figure 1 and immunoprecipitated with anti-cyclin B1 antibody. A`wash o assay' was employed where the immunoprecipitate was incubated with the indicated amounts of recombinant Gadd45 or NAP1, then rinsed to remove dissociated protein, and then analysed by (see Materials and methods). Following incubation, immunoprecipitates were washed again with lysis buer, and the ®nal immunoprecipitate was analysed by SDS ± PAGE gel electrophoresis and immunoblotting with monoclonal Cdc2 antibody. Prior to the ®nal immunoprecipitation, an aliquot of the solution was analysed by immunoblotting with an anti-cyclin B1 antibody to con®rm uniform loading and is shown in the lower panel or NAP1; the complexes were then washed again, and analysed by gel electrophoresis and immunoblotting with Cdc2 antibody. The expectation was that if Gadd45 protein was able to disrupt Cdc2/Cyclin B1 complex, then the second rinse should remove dissociated Cdc2 protein from the Cyclin B/antiCyclin-B1 antibody immune complexes. As shown in Figure 4 , increasing amounts of Gadd45 reduced the Cdc2 level in these immune complexes, while the NAP-1 control had no eect. To con®rm uniform levels of Cyclin B1, the amount of Cyclin B1 was measured by immunoblotting. Thus, Gadd45 was able to dissociate Cdc2/Cyclin B1 complexes in vitro in a dose dependent manner.
To explore the eect of Gadd45 on Cdc2/cyclin B1 in vivo, Cdc2 kinase activity was examined in human p53 wt RKO cells and several sublines that express high levels of antisense GADD45 RNA. These antisense lines have been shown previously to have more than a ®vefold reduction in Gadd45 expression compared to the parental line, and increased Gadd45 expression following induction by UV radiation was completely blocked . The growth rate of these lines was equivalent and all showed a similar G1 arrest after IR. As shown in Figure 5 , the levels of Cdc2/Cyclin B1 kinase activity were similar in unirradiated cells. However, following UV irradiation the parental line showed a strong reduction in Cdc2 kinase activity, while the inhibition was signi®cantly attenuated in all the antisense sublines, two of which are shown in this ®gure. This result correlates with the attenuated G2 checkpoint activation after UV radiation that was recently observed in the same antisense lines (Wang et al., 1997 ; submitted for publication).
Discussion
Cdc2/Cyclin B1 complex plays a central role in progression from G2 to M phase, and our results indicate that Gadd45 directly associates with Cdc2 and inhibits its activity. In vitro, Gadd45 was found to displace Cyclin B1 from the Cdc2 complex; if similar eects occur in vivo then this would represent another mechanism whereby Cdc2 activity is controlled after genotoxic stress. In addition, Cyclin B1 is more stable when associated with Cdc2 and the reduced stability of free Cyclin B1 may further contribute to G2 delay by Gadd45 (Elledge, 1996) . These results are consistent with the observation that co-expression of a Cyclin B1 expression vector with the Gadd45 expression vector reduced the ability of Gadd45 to trigger G2/M arrest (Wang et al., 1997 ; submitted for publication). Gadd45 is also known to associate with PCNA and p21
Cip1/Waf1 (Kearsey et al., 1995) , however Gadd45 did not require p21
Cip1/Waf1 for G2 arrest in (Wang et al., submitted for publication), and association with Cdc2 did not require either p21
Cip1/Waf1 or PCNA based on our in vitro results (Figure 1) . As discussed earlier, regulation of G2/M progression is complex and there are multiple potentially redundant controls. In the case of a strand-breaking agent like IR, activation of G2 delay is critical due to the clastogenic eect of unrepaired breaks in mitosis; multiple mechanisms have evolved to recognize even rare strand breaks and prevent onset of mitosis (Elledge, 1996; Hartwell and Kastan, 1994; Paulovich et al., 1997) . In contrast, base damage, such as caused by UV radiation or MMS, probably has less catastrophic eects during mitosis and the cellular response diers from that of IR; e.g., UV sensitivity is relatively normal in the checkpoint-de®cient disorder ataxia telangiectasia (mutant ATM) compared to IR and other radiomimetic agents (Hartwell and Kastan, 1994) . In addition, there is no known Gadd45 homolog in yeast and we have been unable to detect it in Drosophilia cells. In mammalian cells and probably other vertebrates, gadd45 has been wellconserved and is a member of a 3-gene family which all share approximately 60% homology and have all been associated with growth control . Thus, Gadd45 and perhaps the other family members probably represent an additional G2 control protein that has been added during metazoan evolution, and contribute to the multiplicity of G2 checkpoint controls required to protect the ®delity of mitosis.
Based on our results in Figures 1c and 3a , the central portion of Gadd45 was required for eective association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity. An examination of this region revealed that it is required for binding of p21 Cip1/Waf1 ; e.g., a peptide spanning positions 65 ± 84 bound p21 Cip1/ Waf1 in vitro (Antinore, unpublished results). However, microinjection of our GADD45 expression vector caused an identical response in CIP1/WAF17/7 cells as in CIP1/WAF1+/+ HCT116 cells (Wang et al., 1997) . Interestingly, Gadd45 has recently been found to be a chromatin-associated protein (Carrier et al, submitted for publication), and shows appreciable homology to the chromatin-associated proteins nucleophosmin at positions 59 ± 68 in Gadd45 and Crm-1 (chromatin region maintenance protein) at positions 68 ± 79 in Gadd45. Whether an interaction with chromatin contributes to Gadd45's role in Cdc2 inhibition in vivo remains to be determined, but our in vitro results were carried out in the absence of core histones and chromatin.
Detection of an in vivo association of Gadd45 with Cdc2 presented several challenges. Gadd45 is a low abundance protein and detection of cellular Gadd45 by immunoblotting with available antibodies has sometimes been challenging. In an earlier report , association with PCNA was detected by immunoprecipitation with our 30T14 monoclonal antibody to Gadd45 (Kilpatrick et al., 1995) , while association with various cdk's, including Cdc2, was not observed. For these reasons, a higher level expression of epitope-tagged Gadd45 following transient transfection was used in Figure 3c . While only a minority of the cells would be expected to take up and express this vector using this approach, there was strong expression. After immunoprecipitation with Cdc2 antibody, an association with Gadd45 could be seen using two dierent epitope tags. Even though the Myc-tag antibody eectively immunoprecipitated the Myc-tagGadd45 (Figure 3c lane 8) , we were unable to detect Cdc2 by immunoblotting the same immunoprecipitate. The reason for this inability to detect Cdc2 after immunoprecipitation with Gadd45 antibodies is uncertain, but may could possibly be due to steric hindrance or otherwise masking available epitopes of this small protein when associated with Cdc2 complexes in vivo.
A role for Gadd45 in G2 was somewhat unexpected based on our earlier observations. However, as discussed earlier, the G1 checkpoint protein p21
Cip1/Waf1 has recently also been implicated in a G2 delay (Dulic et al., 1998; Medema et al., 1998) . Over-expression of Gadd45 has previously been found to inhibit growth in both p53 wt and p53-de®cient lines using colony survival assays . In H1299 cells, which are a p53-de®cient human lung line, transfection of quiescent G0 cells with a Gadd45 expression vector reduced the fraction of cells entering into S phase 9 h after serum stimulation. In contrast, normal human ®broblasts accumulated in G2/M 24 ± 72 h after microinjection with a Gadd45 expression vector, while p53-de®cient ®broblasts did not (Wang et al., 1997 ; submitted for publication). The reason for the requirement for p53 in this G2/M arrest is uncertain but could presumably involve other p53 eectors, such as 14-3-3s, or perhaps p53 itself. In addition, it should be noted that our ®ndings for a role for Gadd45 in G2 control does not preclude other cell cycle regulatory roles for this wellconserved mammalian protein. Whether p21 Cip1/Waf1 contributes to this G2 checkpoint remains to be determined, but as discussed earlier, over-expression of Gadd45 caused caused an identical response in CIP1/WAF17/7 cells as in CIP1/WAF1+/+ HCT116 cells (Wang et al., 1997) .
Gadd45 is one of an increasing number of cell-cycle control proteins that have been found to be regulated by p53. As discussed earlier, while Gadd45 has some similarities to the major G1 checkpoint mediator p21 Cip1/Waf1 , there are important dierences. In contrast to p21 Cip1/Waf1 , which interacts with multiple Cdk complexes and strongly inhibits their kinase activity, Gadd45 has not been found to associate with other Cdk proteins and did not inhibit Cdk2/cyclin Eassociated histone H1 kinase activity. Dierences between these two proteins are highlighted by our recent observation that HPVE7, which associates with Rb and inactivates Rb pathway, was able to block much of the growth suppression by 21
Cip1/Waf1 but not Gadd45 expression vectors (data not shown). The role for p53 in the IR G2 checkpoint has been controversial (Lanni and Jacks, 1998), but evidence exists that it or its downstream eector genes may contribute as discussed earlier. There are probably multiple G2 control mechanisms and even though p53 is not required for the IR-induced G2 checkpoint, evidence exists that p53 contributes to the stringency of G2 checkpoint control (Fan et al., 1995; Powell et al., 1995) . In the case of the UV/MMS G2 checkpoint, our results indicate that Gadd45, a p53-regulated protein, does contribute and that the normal suppression of Cdc2/Cyclin B1 activity after UV irradiation is attenuated in cells with reduced Gadd expression.
Materials and methods

Cells and cell treatment
The human colon carcinoma line RKO was grown in modi®ed Ham's F12 medium supplemented with 10% fetal bovine serum. For UV irradiation, 150-mm dishes were rinsed with PBS (phosphate-buered saline) and irradiated with germicidal lamps at a dose rate of 2.1 Jm 72 /s at 254 nm. The original medium was replaced and the cells were returned to 378C for 4 h, and then cells were harvested for the preparation of cellular protein.
Transfection
For mammalian cell transfections, 10 6 RKO cells were seeded onto 100 mm plates the day before transfections. For each plate to be transfected, 5 mg of DNA and 14 ml of Lipofectamine (Gibco-BRL) were each diluted in 300 ml of Opti-Mem (Gibco-BRL) in separate tubes. Solutions were mixed with vortexing, allowed to sit 10 ± 15 min at room temperature, diluted with 2.4 ml Opti-Mem and added to the plate for 5 h. An equal volume of media with 10% FCS was added and plates were left overnight. Fresh media was added the following day and cells were harvested 48 h later.
Expression constructs
Internal Gadd45 primers were designed to contain an inframe 5' NdeI site and were used to amplify the desired regions from a human Gadd45 cDNA construct, pHul45B2 (Papathanasiou et al., 1991) . PCR products were cloned into the pcrII vector using the TA Kit (Invitrogen) and sequenced prior to sub-cloning into NdeI/XhoI digested pET14b vector. This series of vectors allowed production of histidine tagged bacterial proteins. To construct the Myc-tagGadd45 expression vector, internal Gadd45 primers were designed to contain an in-frame 5' NdeI site and were used to amplify the desired regions from a human Gadd45 cDNA construct. PCR products were cloned into the pcrII vector using the TA Kit (Invitrogen, Carsbad, CA, USA) and sequenced prior to subcloning into XhoI/XbaI cut pCS2MT. This allowed expression of the Gadd45 constructs tagged with six copies of the Myc epitope recognized by the monoclonal 9E10 antibody at the amino-terminus (Rupp et al., 1994; Turner and Weintraub, 1994) . For the construction of glutathione-S-transferase fusion protein expression vector, the GADD45 insert was PCR ampli®ed from pHul45B2 using the following primers: 5'-GGCGGCTCGAGACTTTGGAG-GAATTCTCGGC-3' and 5'-CATCACCGTTCAGGGAGA-TTAATC-3'. Products were cloned into the pcrII vector using the TA cloning kit (Invitrogen) and a representative clone was con®rmed by sequencing. The selected insert was removed by XhoI and NotI digestion, gel puri®ed using the Wizard DNA Puri®cation Kit (Promega, Madison, WI, USA), and ligated into the XhoI/NotI digested pGEX4T vector (Pharmacia, Piscataway, NJ, USA).
Recombinant proteins
GST-Gadd45 fusion protein induction was prepared from freshly transformed BL21 bacterial cells (Novagen). One hundred ®fty ml of overnight culture was diluted into 1L of LB with ampicillin and grown at 378C to late growth phase (OD 600 was approximately 0.8). Cultures were allowed to cool to 288C, before induction with 0.5 mM IPTG for 2 h at 288C. Cultures were spun down, resuspended in PBS+0.1% NP-40, lysed by sonication, passed through a 0.45 mm syringe ®lter and cleared by centrifugation. The supernatent was passed over a column of glutathione-conjugated Sepharose beads (Pharmacia) and were washed with PBS containing 0.1% NP-40. The Sepharose beads were suspended in an equal volume of the same solution and stored in aliquots at 7708C. Gadd45 recombinant proteins were prepared and the histidine tag was removed as described previously ; submitted for publication); proteins included the full-length and truncated forms containing the ®rst 124, Gadd45D125 ± 166, or ®rst 71, Gadd45D72 ± 166, amino acids. p21
Cip1/Waf1 was provided by Dr S Elledge. The yeast recombinant NAP-1 protein was puri®ed as described in (Fujii-Nakata et al., 1992) with the following modi®cation: the E. coli BL21 (DE3) bacterial strain transformed with pTN2 (NAP-1 expression plasmid) were lysed by sonication in presence of 0.1% NP-40. The pTN2 plasmid was provided by Akihilo Kikuchi, Tokyo, Japan.
Antibodies and immunoprecipitation
Antibodies against human Cdc2, c-Myc, and NAP-1 were commercially provided by Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies to cyclin B1, cyclin E, Cdk2 (14471A), and p21
Cip1/Waf1 were obtained from Pharmingen (San Diego, CA, USA). For immunoprecipitation, exponentially growing RKO cells were lysed on ice for 30 min in lysis buer consisting of 50 mM Tris-HCl (pH 7.5), 120 mM NaCl, 1% NP-40, 2 mg/ml of aprotinin, 2 mg/ml of leupetin and 100 mg/ml of phenylmethylsulfony¯uoride. One mg of cellular protein was immunoprecipitated with anti-Cyclin B1 antibody and protein A agarose beads (Santa Cruz, CA, USA) for 4 h at 48C. The immunoprecipitates were washed three times with lysis buer and then loaded onto a SDS ± PAGE gel for immunoblot analysis.
To detect binding of cellular Cdc2 to GST-tagged Gadd45, 100 ng of GST or GST-Gadd45 fusion protein were incubated with one mg of RKO cellular protein for 4 h at 48C. Complexes were then washed three times with lysis buer and loaded onto a 12% SDS ± PAGE gel. Following electrophoresis, the proteins were electrophoretically transferred to Immobin membranes (Millipore, Bedford, MA, USA). The membranes were blocked for 30 min in 5% nonfat milk and then incubated with anti-Cdc2 (Santa Cruz, CA, USA) and anti-cyclin B1 (Pharmingen, CA) monoclonal mouse antibodies. Antibody was detected by a chemiluminescence system in accordance with the instructions of the manufacturer (Amersham, Buckinghamshire, England).
Kinase assay
Puri®ed Cdc2-Cyclin B1 complexes (Upstate Biotechnology, Lake Placid, NY, USA) were incubated with the indicated amounts of recombinant Gadd45 (full-length Gadd45 or truncated forms) or NAP1 proteins for 5 min. Histone H1 kinase assays were then performed in the presence of 10 mg of histone H1 (Upstate, Lake Placid, NY, USA), 15 mM MgCl 2 , 7 mM b-glycerol phosphate, 1.5 mM EGTA, 0.25 mM sodium orthvanadate, 0.25 mM DTT and 10 mCi of [g-32 P]ATP in 25 ml. After 15 min at 378C, the reactions were mixed with an equal amount of standard 26 SDS protein denaturation loading buer, size-separated on a 12% SDS ± PAGE gel, and analyzed by autoradiography.
ELISA assay
Immulon II immunoabsorption plates (Dynatech) were coated with 100 ng of Cdc2/Cyclin B1 complexes (Upstate Biotechnology, Lake Placid, NY, USA) in PBS and incubated overnight at 48C. After rinsing with PBST (PBS with 0.05% Tween-20) and blocking in 5% nonfat milk in PBST, 40 ng of recombinant Gadd45 protein were added. Following incubation for 1 h at room temperature, the plates were washed and an anti-Gadd45 antibody (Zymed, San Francisco, CA, USA) was added at a 1 : 1000 dilution in PBST with 0.5% milk (PBSTM). After 1 h at 258C, the plates were washed, and HRP-anti-rabbit antibody diluted at 1 : 1000 in PBSTM was added before ®nal washes and development using the 1-step TMB Solution (Pierce, Rockford, IL, USA). Development was halted by the addition of 50 ml of 1 M H 2 SO 4 , and optical density was measured using a platereader.
Cdc/Cyclin B1 dissociation assay
Dissociation of Cdc2/Cyclin B1 by Gadd45 in vitro was performed with a`wash o assay.' Brie¯y, RKO cellular protein was immunoprecipitated with anti-Cyclin B1 antibody. The immunoprecipitates were washed three times with lysis buer and twice with 10 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 . Samples were then suspended in 30 ml of 10 mM TrisHCl (pH 7.5), 10 mM MgCl 2 . The indicated amount of recombinant Gadd45 or NAP1 was added to the Cdc2/ Cyclin B1 immunocomplexes and incubated for 15 min at 258C. Following incubation, immunoprecipitates were washed twice with lysis buer, loaded onto SDS ± PAGE gel for electrophoresis, and the membrane was immunoblotted with monoclonal Cdc2 antibody for the detection of Cdc2 protein.
Prior to the ®nal immunoprecipitation, an aliquot of the solution was analysed by immunoblotting with an anti-Cyclin B1 antibody to con®rm uniform loading.
